Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma

NCT01928771 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2681

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

BIOLOGICAL: Benralizumab
BIOLOGICAL: Placebo

Sponsor

AstraZeneca